VelociGene ® ES: High-Throughput Engineering of the Mouse Genome

VelociGene is a novel method developed by Regeneron scientists which has revolutionized the process of gene targeting in ES cells. This method allows for a dramatic increase in the speed and throughput at which targeted ES cells can be generated, while at the same time increasing the precision, flexibility and complexity of the genetic modification. VelociGene achieved these improvements by incorporating two enabling innovations:

1. BacVec Targeting Vectors

VelociGene's use of BacVecs has greatly streamlined the process of making a knockout mouse while providing maximum flexibility for allele design. After obtaining a BAC clone of the target gene, we use bacterial homologous recombination to construct the knockout or other allele. The modified BAC is simply linearized, without additional trimming, to create the BacVec targeting vector prior to introduction into ES cells. In addition to simplifying construction, the long homology arms of BacVecs promote efficient homologous recombination in ES cells and enable larger deletions in a single targeting step than are possible with conventional targeting vectors.

2. The Loss of Allele Screening Assay

To take full advantage of BacVecs as targeting vectors we developed a proprietary Loss of Allele (LOA) assay, which employs quantitative PCR (Q-PCR) to detect the loss of one of the native target gene alleles upon recombination with the BacVec. We complement the LOA assay with a Q-PCR that quantifies the number of copies of the inserted reporter-selection cassette, valuable information not usually obtained by standard screening methods. For a correctly targeted ES cell clone the LOA assay indicates loss of one allele and gain of one copy of the reporter-selection cassette.

In developing VelociGene our goal was to bring to the process of knockout mouse production the speed, reliability, high throughput, and scalability of an industrial assembly line while retaining the precision and flexibility in allele design of a custom research project.

For inquires regarding VelociGene licensing or partnership opportunities, please contact us at business.development@regeneron.com.

News & Publications genome
September 7, 2006
VelociGene technology selected for the NIH Knockout Mouse Project (KOMP)

More News | Publications
KOMP KOMP
Regeneron Will Use its VelociGene® Technology to Target Genes, Providing New Models of Human Disease.

Data Access
Industry-Leading Timelines timeline
Fastest from concept to Knockout mice without sacrificing precision and complexity.

Learn about our services
The Power of Gene Reporting lacZ Gallery
VelociGene allows scientists to rapidly identify the physical and biological effects of deleting or over-expressing the target gene. View Slideshow